During the past decade, Azienda Ospedaliera Santa Maria degli Angeli conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Santa Maria degli Angeli" #1 sponsor was "National Cancer Institute, Naples" with 7 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Biotronik SE & Co. KG" with 2 trials sponsored, "Gruppo di Ricerca GISSI" with 2 trials sponsored and "IRCCS Burlo Garofolo" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Santa Maria degli Angeli" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 2 trials as a collaborator, "Lund University" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator and "Aventis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Santa Maria degli Angeli" are "Ovarian Cancer" (5 trials), "Head and Neck Cancer" (2 trials), "Heart Failure" (2 trials), "Out-of-hospital Cardiac Arrest" (2 trials) and "Acute Pain Due to Trauma" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Santa Maria degli Angeli" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Santa Maria degli Angeli" are "Drug" (21 trials), "Procedure" (6 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (3 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Santa Maria degli Angeli" are 24 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Santa Maria degli Angeli". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Azienda Ospedaliera Santa Maria degli Angeli, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Santa Maria degli Angeli, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".